by healthadvances Posted on February 15, 2022 Women’s Health at Home: Reflections on a Rapidly Growing Space Read More
by healthadvances Posted on June 30, 2021 Tencent-Backed Wedoctor Is Going Public: What Are the Next Steps for Chinese Digital Health Companies? Read More
by healthadvances Posted on September 18, 2020 How COVID-19 Testing Demand Threw off Thermo Fisher’s Acquisition of Qiagen Read More
by healthadvances Posted on September 15, 2020 Hong Kong Exchange: Nurturing China’s Biotech Valley Read More
by healthadvances Posted on July 30, 2020January 13, 2021 Value Creation in Molecular Diagnostics: A Game of Luck or Skill? Read More
by healthadvances Posted on July 16, 2020July 17, 2020 Is Cardiovascular R&D Ready for a Comeback? Read More
by healthadvances Posted on April 24, 2020 The Great Lockdown of 2020: Will the Life Sciences Emerge Unscathed? Read More
by healthadvances Posted on February 27, 2019April 13, 2020 SHIFTING TIDES IN PHARMA DEALMAKING Read More
by healthadvances Posted on February 27, 2019November 13, 2020 Danaher’s Massive Biopharma Acquisition: It’s the Fit that Counts Read More
by healthadvances Posted on December 19, 2018April 13, 2020 The Year That Was: Oncology Edition Read More
